Vision Oncology - Every life matters Vision Oncology - Every life matters
Vision Oncology - Every life matters Vision Oncology - Every life matters
Vision Oncology - Every life matters Vision Oncology - Every life matters
Vision Oncology - Every life matters Vision Oncology - Every life matters
Vision Oncology - Every life matters Vision Oncology - Every life matters

VISION
Oncology

Vision pushes boundaries, bridging the gap between cutting-edge technology and healthcare.

Whether it’s nanoparticles formulation or hi-tech equipment development, its commitment to innovation remains unwavering.

Dream big,
think concretely,
work hard.

Vision is a company of down-to-earth dreamers established in 2022. We are dreamers because we dream of a world in which cancer kills fewer people than it does today and because we want treatments that can be available to all patients.

Meet our Team

Vision Oncology

Destroys tumor masses
with radio frequences

Nanoradox is a Class III medical device that, in in-vivo studies, shows an inhibition of the growth of the tumor mass by over 50%.

Nanoradox is a non-invasive, non-toxic hyperemic treatment that can support pharmacological therapies. It is essential for extending patients’ lives and significantly increasing their quality of life during and after the illness.

Find out more

Patent pending n. 23157097.9

New frontiers in oncological research

Simplicity is the ultimate sophistication

Leonardo Da Vinci